RETT CORP has a total of 15 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets chemical engineering, measurement and pharmaceuticals are TSUDA TAKAO, MICROSCAL LTD and TIANJIN XIANQUAN IND AND TRADE DEVELOPMENT CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | Japan | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Chemical engineering | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Separation | |
#3 | Chemical or physical processes | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Moaddel Ruin | 8 |
#2 | Wainer Irving | 8 |
#3 | Zhang Yanxiao | 5 |
#4 | Beigi Farideh | 4 |
#5 | Wainer Irving W | 4 |
#6 | Parenti Carlo | 3 |
#7 | Braghiroli Daniela | 3 |
#8 | Tait Annalisa | 3 |
#9 | Zhang Yanxiano | 3 |
#10 | Baraldi Mario | 3 |
Publication | Filing date | Title |
---|---|---|
WO03054514A2 | Novel parallel throughput system | |
WO03050503A2 | Multiple binding moiety chromatography device, methods of using and methods of making same | |
CA2412556A1 | Immobilized g-protein coupled receptors on liquid chromatography stationary phases and use thereof for on-line screening | |
EP1435926A2 | Method for treatment and prevention of disturbances of the central nervous system associated with an alteration of glutamatergic neurotransmission by administration of 2-aminobenzenesulfonamide derivatives | |
EP1064316A1 | Immobilization of membrane receptor on hplc |